FY2026 Earnings Forecast for EYPT Issued By Chardan Capital
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Analysts at Chardan Capital issued their FY2026 earnings per share estimates for shares of EyePoint Pharmaceuticals in a report issued on Monday, March 24th. Chardan Capital analyst D. Gataulin expects that the company will post earnings of ($2.82) per share for the year. Chardan Capital has a […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Analysts at Chardan Capital issued their FY2026 earnings per share estimates for shares of EyePoint Pharmaceuticals in a report issued on Monday, March 24th. Chardan Capital analyst D. Gataulin expects that the company will post earnings of ($2.82) per share for the year. Chardan Capital has a […]
